鲁索替尼乳膏(Ruxolitinib cream)有效期多长时间

Introduction: Ruxolitinib Cream (Ruxolitinib cream) is mainly used to treat inflammatory skin diseases such as atopic dermatitis. The correct storage and use of this drug is crucial, especially its validity period and storage conditions, which directly affect the efficacy and safety of the drug. Understanding its prohibition and caution is also an important part of ensuring safe medication use by patients.

Validity period and storage conditions

The validity period of ruxolitinib cream is usually 24 months, that is, within two years from the date of production. The drug should be kept under specified storage conditions to ensure its stability and effectiveness. During storage, the medicines need to be sealed and packaged to prevent them from being affected by the external environment. At the same time, the medicines should be stored at room temperature of 20-25°C. It is worth noting that the temperature is allowed to have a certain excursion between 15-30°C, but extreme temperature conditions such as high temperatures or freezing should be avoided. In addition, medicines should be placed in a dry place away from moisture and direct sunlight to prevent them from deteriorating or becoming ineffective.

Ruxolitinib CreamContraindications

Contraindicated in patients with hereditary diseases: Patients with rare hereditary galactose intolerance, lactose deficiency or problems with glucose-galactose malabsorption should avoid using this drug. The special metabolic conditions of these patients may result in the inability to metabolize certain components of the drug normally, leading to adverse reactions.

Contraindicated for specific groups: Pregnant women should not use it because the drug may have adverse effects on the fetus. In addition, it is also contraindicated in patients with severe bone marrow suppression to avoid aggravating the condition or causing serious complications.

Prudent use information of ruxolitinib cream

Patients with hepatic and renal insufficiency: Patients with hepatic and renal insufficiency should be particularly cautious when using ruxolitinib cream, because these patients may not be able to effectively metabolize or excrete the drug, causing the drug to accumulate in the body and increasing the risk of adverse reactions.

Patients with a history of infection and previous treatment: Patients with bacterial or viral infections, as well as patients who have previously received chemotherapy or radiation therapy, should consult their doctor before using ruxolitinib cream, as these conditions may affect the efficacy of the drug or increase the risk of adverse reactions.

Elderly patients: Elderly patients over 70 years old should use ruxolitinib cream with caution, because the elderly are often accompanied by a variety of chronic diseases and decline in physiological functions, and their tolerance to the drug and metabolism may decrease. If it is really necessary to use it, it should be done under the guidance of a doctor, and changes in the condition should be closely monitored.